The 14‐3‐3/SLP76 protein–protein interaction in T‐cell receptor signalling: a structural and biophysical characterization

The SH2 domain‐containing protein of 76 kDa, SLP76, is an important adaptor protein that coordinates a complex protein network downstream of T‐cell receptors (TCR), ultimately regulating the immune response. Upon phosphorylation on Ser376, SLP76 interacts with 14‐3‐3 adaptor proteins, which leads to...

Full description

Saved in:
Bibliographic Details
Published in:FEBS letters Vol. 595; no. 3; pp. 404 - 414
Main Authors: Soini, Lorenzo, Leysen, Seppe, Davis, Jeremy, Westwood, Marta, Ottmann, Christian
Format: Journal Article
Language:English
Published: England 01.02.2021
Subjects:
calorimetry
crystal structure
fluorescence
immune response
isothermal titration calorimetry
phosphorylation
protein constructs
protein-protein interactions
proteolysis
surface plasmon resonance
synthetic peptides
T-lymphocytes
TCR signalling and 14‐3‐3
titration
X‐ray protein crystallography
isothermal titration calorimetry
protein constructs
surface plasmon resonance
TCR signalling and 14-3-3
X-ray protein crystallography
ISSN:0014-5793, 1873-3468, 1873-3468
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The SH2 domain‐containing protein of 76 kDa, SLP76, is an important adaptor protein that coordinates a complex protein network downstream of T‐cell receptors (TCR), ultimately regulating the immune response. Upon phosphorylation on Ser376, SLP76 interacts with 14‐3‐3 adaptor proteins, which leads to its proteolytic degradation. This provides a negative feedback mechanism by which TCR signalling can be controlled. To gain insight into the 14‐3‐3/SLP76 protein–protein interaction (PPI), we have determined a high‐resolution crystal structure of a SLP76 synthetic peptide containing Ser376 with 14‐3‐3σ. We then characterized its binding to 14‐3‐3 proteins biophysically by means of fluorescence polarization and isothermal titration calorimetry. Furthermore, we generated two recombinant SLP76 protein constructs and characterized their binding to 14‐3‐3. Our work lays the foundation for drug design efforts aimed at targeting the 14‐3‐3/SLP76 interaction and, thereby, TCR signalling.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0014-5793
1873-3468
1873-3468
DOI:10.1002/1873-3468.13993